Klotho Neurosciences Stock (NASDAQ:KLTO)
Previous Close
$0.52
52W Range
$0.11 - $3.91
50D Avg
$0.34
200D Avg
$0.63
Market Cap
$27.63M
Avg Vol (3M)
$3.19M
Beta
2.23
Div Yield
-
KLTO Company Profile
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.